Twist Bioscience Corporation (TWST)
NASDAQ: TWST · IEX Real-Time Price · USD
30.75
-0.75 (-2.38%)
At close: Apr 24, 2024, 4:00 PM
30.70
-0.05 (-0.16%)
After-hours: Apr 24, 2024, 7:22 PM EDT
Twist Bioscience Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Twist Bioscience stock have an average target of 34.6, with a low estimate of 18 and a high estimate of 45. The average target predicts an increase of 12.52% from the current stock price of 30.75.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for TWST stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 2 | 2 |
| Buy | 5 | 5 | 2 | 3 | 3 | 3 |
| Hold | 2 | 2 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 4 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $45 → $40 | Buy | Maintains | $45 → $40 | +30.08% | Apr 10, 2024 |
| Scotiabank | Scotiabank | Buy Maintains $30 → $43 | Buy | Maintains | $30 → $43 | +39.84% | Feb 5, 2024 |
| Barclays | Barclays | Buy Maintains $30 → $45 | Buy | Maintains | $30 → $45 | +46.34% | Jan 25, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $25 → $45 | Strong Buy | Maintains | $25 → $45 | +46.34% | Jan 18, 2024 |
| Goldman Sachs | Goldman Sachs | Hold → Strong Buy Upgrades $25 → $45 | Hold → Strong Buy | Upgrades | $25 → $45 | +46.34% | Jan 17, 2024 |
Financial Forecast
Revenue This Year
299.11M
from 245.11M
Increased by 22.03%
Revenue Next Year
361.20M
from 299.11M
Increased by 20.76%
EPS This Year
-3.14
from -3.60
EPS Next Year
-2.72
from -3.14
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 315.0M | 404.1M | 508.8M |
| Avg | 299.1M | 361.2M | 432.2M |
| Low | 284.7M | 333.6M | 385.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 28.5% | 35.1% | 40.9% |
| Avg | 22.0% | 20.8% | 19.7% |
| Low | 16.1% | 11.5% | 6.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -2.98 | -2.07 | -1.29 |
| Avg | -3.14 | -2.72 | -2.46 |
| Low | -3.18 | -2.99 | -3.31 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.